EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense authorization and implementation of the 2017 NDAA.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Executive Office of the President (EOP); Congressional Budget Office (CBO); Internal Revenue Service (IRS); White House Office; Government Accountability Office (GAO); Federal Trade Commission (FTC); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA)

Taxation/Internal Revenue Code TAX

Implementation of tax provisions of the ACA, including the insurer tax. Tax reform policies.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA); Office of Personnel Management (OPM); Labor, Dept of (DOL); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Federal Trade Commission (FTC)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap, direct negotiation of prescription drug prices. Implementation of opioid abuse "lock in" provisions from CARA. Medicare Part B reforms. S. 637; HR 1920; HR 1939. Medical utilization management and Medicare Advantage program policy and operations.

Contacted: Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Government Accountability Office (GAO); Food & Drug Administration (FDA); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Internal Revenue Service (IRS); SENATE; Federal Trade Commission (FTC); Office of Personnel Management (OPM)

Bills named: S. 637 (115th), H.R. 1939 (115th), H.R. 1920 (115th)

Pharmacy PHA

Design and coverage of pharmacy benefits in Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, EPCS, electronic prior authorization, PBM disclosure, MLR, and specialty pharmacy tiering. Implementation of biosimilars pathway from BPCIA. Policies placing restrictions on pharmacy benefit design. Issues relating to prescription drug affordability. REMS reform. Prescription drug user fee reauthorization. HR 1854; S. 788; HR 2025.

Contacted: Congressional Budget Office (CBO); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2025 (115th), S. 788 (115th), H.R. 1854 (115th)

Health Issues HCR

Regulatory policies related to the health reform law, including drug benefits and disclosure. Implementation of HITECH. Prescription drug affordability issues. Reforms to Medicaid and Exchange markets.

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); White House Office; Labor, Dept of (DOL); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)